BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 19433345)

  • 1. Genistein synergizes with RNA interference inhibiting survivin for inducing DU-145 of prostate cancer cells to apoptosis.
    Yuan-Jing F; Nan-Shan H; Lian X
    Cancer Lett; 2009 Nov; 284(2):189-97. PubMed ID: 19433345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells.
    Song H; Xin XY; Xiao F; Wang DT; Yue QH; Han X
    Eur J Obstet Gynecol Reprod Biol; 2008 Jan; 136(1):83-9. PubMed ID: 17098350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of survivin gene by vector-based short hairpin RNA technique induces apoptosis and growth inhibition in Burkitt's lymphoma Raji cell line.
    Gu CM; Zhu YK; Ma YH; Zhang M; Liao B; Wu HY; Lin HL
    Neoplasma; 2006; 53(3):206-12. PubMed ID: 16652189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of survivin expression by small interfering RNA induces apoptosis in human breast carcinoma cell line MCF-7.
    Li JX; Zhou KY; Liang T; Zhang YF
    Ai Zheng; 2005 Mar; 24(3):268-72. PubMed ID: 15757525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer.
    Hou JQ; He J; Wang XL; Wen DG; Chen ZX
    Chin Med J (Engl); 2006 Oct; 119(20):1734-9. PubMed ID: 17097022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
    Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergism between a siRNA targeted to survivin and 5-FU in inhibiting MCF-7 cell proliferation in vitro.
    Zhang SQ; Zhang SH; Xue XH; Wang XJ; Jiang JT
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):251-4. PubMed ID: 16546719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topotecan and small interfering RNA suppress survivin expression synergistically in Caki-1 renal cancer cells: Direct suppression of survivin and enhancement of transfection efficiency by topotecan.
    Sato A; Ito K; Asano T; Sumitomo M; Asano T; Hayakawa M
    Int J Oncol; 2008 Jan; 32(1):171-6. PubMed ID: 18097556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis.
    Nakao K; Hamasaki K; Ichikawa T; Arima K; Eguchi K; Ishii N
    Oncol Rep; 2006 Aug; 16(2):389-92. PubMed ID: 16820920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
    Yoo J; Lee YJ
    Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
    Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M; Mukherjee N; Bermudez RS; Latham DE; Delaney MA; Zietman AL; Shipley WU; Chakravarti A
    Prostate; 2005 Aug; 64(3):293-302. PubMed ID: 15754318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells.
    Chen T; Deng C
    Int Immunopharmacol; 2008 Jul; 8(7):1006-11. PubMed ID: 18486912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of survivin expression enhances sensitivity of cultured uveal melanoma cells to cisplatin treatment.
    Li H; Niederkorn JY; Neelam S; Alizadeh H
    Exp Eye Res; 2006 Jul; 83(1):176-82. PubMed ID: 16584731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.
    Rödel F; Hoffmann J; Distel L; Herrmann M; Noisternig T; Papadopoulos T; Sauer R; Rödel C
    Cancer Res; 2005 Jun; 65(11):4881-7. PubMed ID: 15930309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
    Fuessel S; Herrmann J; Ning S; Kotzsch M; Kraemer K; Schmidt U; Hakenberg OW; Wirth MP; Meye A
    Cancer Lett; 2006 Feb; 232(2):243-54. PubMed ID: 16458121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R; Tsuji N; Moriai M; Kobayashi D; Watanabe N
    Breast Cancer Res Treat; 2009 Sep; 117(2):261-71. PubMed ID: 18815881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blockage of survivin and securin expression increases the cytochalasin B-induced cell death and growth inhibition in human cancer cells.
    Chao JI; Liu HF
    Mol Pharmacol; 2006 Jan; 69(1):154-64. PubMed ID: 16219911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ribozyme-mediated inhibition of survivin expression increases spontaneous and drug-induced apoptosis and decreases the tumorigenic potential of human prostate cancer cells.
    Pennati M; Binda M; Colella G; Zoppe' M; Folini M; Vignati S; Valentini A; Citti L; De Cesare M; Pratesi G; Giacca M; Daidone MG; Zaffaroni N
    Oncogene; 2004 Jan; 23(2):386-94. PubMed ID: 14724567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase 2-dependent expression of survivin is critical for apoptosis resistance in non-small cell lung cancer.
    Krysan K; Dalwadi H; Sharma S; Põld M; Dubinett S
    Cancer Res; 2004 Sep; 64(18):6359-62. PubMed ID: 15374938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.